Skip to NavigationSkip to content


Pfizer buys British vaccine company PowderMed

Pfizer will gain entry into the fast-growing vaccines market by buying PowderMed, the British company developing next generation products in the field.

PowderMed's vaccine pipeline is based on its Particle Mediated Epidermal Delivery (PMED) technology, a needle-free delivery system that delivers DNA-coated microscopic gold particles into the skin using pressurised helium gas. The particles penetrate the skin, activating cells that, in turn, trigger an immune response.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches